Friday, August 28, 2026
New Guidelines Aim to Bring Precision Medicine to Stroke Rehabilitation
A University of Maryland School of Medicine (UMSOM) stroke rehabilitation specialist helped develop new recommendations for studying molecular biomarkers associated with recovery from stroke. The new guidelines could help pave the way for precision rehabilitation approaches tailored to individual patients.
Tuesday, August 25, 2026
New Clinical Tool Helps Predict Short-term Risk of Diabetes Complications Using Routine Health Data
Researchers at the University of Maryland School of Medicine (UMSOM) have developed and validated a new risk calculator that can estimate an individual patient’s short-term risk of developing a range of diabetes-related complications, using information already collected during routine medical care.
Thursday, August 20, 2026
UMSOM Welcomes its Newest Class During 30th Annual White Coat Ceremony
The University of Maryland School of Medicine (UMSOM) Class of 2030’s journey to becoming medical professionals officially kicked off August 7 at the annual White Coat Ceremony.
Wednesday, August 19, 2026
Climate Change Predicted to Drive Changes in Diarrheal Disease Prevalence in Several Countries in Africa
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have identified key social and environmental factors that influence how climate change affects childhood diarrheal diseases in sub-Saharan Africa. An August study published in Nature Communications found that while rising temperatures and changing rainfall patterns are likely to alter disease risks, factors such as vaccination, access to transportation, and other indicators of socioeconomic resilience can help reduce the impact of climate-related health threats. A second study that did an initial analysis of the data was published in the Journal of Infectious Diseases in June.
Thursday, August 06, 2026
New Study Finds Bacterial Infections Affect About 1 in 20 Hospitalized Adults With Firearm Injuries
A new study from researchers at the University of Maryland School of Medicine (UMSOM) found that bacterial infections develop in approximately 5 percent of adults hospitalized with firearm injuries, with most infections occurring during the initial hospitalization rather than after patients return home. The findings were published Aug. 3 in JAMA Network Open as a research letter.
Thursday, July 30, 2026
Clinicians Should Include E-Cigarettes in Smoking Cessation Discussions with Tobacco Smoking Patients, New Consensus Recommendations Find
Clinicians should include nicotine-containing e-cigarettes alongside other evidence-based options for quitting cigarette smoking in conversations with adult patients, according to a new Special Communication published today in JAMA that is co-authored by a University of Maryland School of Medicine faculty member. The group of 24 tobacco treatment and addiction experts was convened by the Society for Research on Nicotine and Tobacco (SRNT) and was tasked with reviewing the latest literature to make recommendations directed at healthcare practitioners.
Thursday, July 30, 2026
Nationally Recognized Pediatric Oncologist Named Director of Pediatric, Adolescent and Young Adult Cell and Gene Therapy Program
Nirali N. Shah, MD, MHSc, a nationally-recognized pediatric oncologist at the National Cancer Institute (NCI), has been appointed Professor and Director of the Pediatric/Adolescent and Young Adult Cell and Gene Therapy Program at University of Maryland School of Medicine. She will also serve as Associate Director for Translational Research for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) .
Wednesday, July 29, 2026
UM School of Medicine Establishes Two Endowed Professorships in Gene & Cell Therapy and Pediatric Cardiac Surgery through Maryland E-Nnovation Awards
The University of Maryland, Baltimore (UMB) has been awarded $1.5 million in matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce, to establish two new endowed professorships at the University of Maryland School of Medicine (UMSOM). Combined with $1.5 million in matching qualified funding from the university, the awards total $3 million and will support the recruitment of two physician-scientists to advance research and clinical innovation in gene and cell therapy and pediatric cardiac surgery, UMSOM Dean Mark T. Gladwin, MD, announced today.
Friday, July 24, 2026
Internationally Recognized Expert Leads University of Maryland School of Medicine Program in Sickle Cell Disease
Enrico M. Novelli, MD, MS, has been named Director of the University of Maryland School of Medicine (UMSOM) Program in Sickle Cell Disease and a Professor in the Department of Medicine, Division of Hematology/Oncology. An internationally recognized expert in sickle cell disease, he will treat patients at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) and serve as Chief of the University of Maryland Medical System (UMMS) Sickle Cell Disease and Classical Hematology Network, a new initiative to expand access to care for patients with sickle cell disease across Maryland.
Wednesday, July 22, 2026
Cruise Ship Hantavirus Outbreak Highlights Need for Clear Public Health Communication and Global Disease Preparedness
A small outbreak of a rare hantavirus on a cruise ship earlier this year captured worldwide attention and sparked concerns about a possible new pandemic. But according to a new University of Maryland School of Medicine (UMSOM) commentary published in JAMA Internal Medicine, the outbreak posed little risk to the general public and offers important lessons about how health officials, scientists, and the media should communicate during emerging disease events.